Human Milk Oligosaccharides and Childhood Diarrhoea

NCT02896465 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 435

Last updated 2019-07-23

No results posted yet for this study

Summary

Assessment of the impact of oral Human Milk Oligosaccharides (HMO) application on acute diarrhoea and the development of prolonged and persistent diarrhoea in paediatric patients hospitalized with acute diarrhoea.

Conditions

  • Acute Diarrhea

Interventions

OTHER

Oral rehydration solution

OTHER

Zinc

OTHER

Human milk oligosaccharides

OTHER

Breastfeeding

Sponsors & Collaborators

  • Société des Produits Nestlé (SPN)

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
6 Months
Max Age
2 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-06-30
Primary Completion
2018-10-31
Completion
2019-02-28

Countries

  • Bangladesh

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02896465 on ClinicalTrials.gov